DOSSIER·REF / RP-3·CAS 2381089-83-2
SECURE CHANNEL · LIVE
VALIDATION · HPLC-CERTIFIED
≥99%
Research Compliance
For In-Vitro Laboratory Research only. Not for human or animal consumption. This material is supplied as an analytical reference standard for laboratory research. It is not a medicine, food, cosmetic or medical device.
ANALYTICAL REFERENCE
RP-3
5mgView test report
10mgView test report
15mgView test report
30mgView test report
LIMITED OFFER · -25%
€48.74€64.99PER UNIT
€4.99Free from €100 · 1-2d delivery
CHOOSE VARIANT
VOLUME TIERS · BULK DISCOUNT
1× MORE FOR −5%// Discount counts against the total of Peptides & Orals in your cart.
1
COMPOUND PROFILE
Triple-agonist next-generation incretin research peptide (Phase III body-weight studies).
LIVE ANALYSIS MONITOR
JANOSHIK · ≥99%
Independent HPLC / MS Analysis
Analytical certificate issued by Janoshik Analytical · Identity, purity and lot authenticity verified against retention-time and parent-ion mass references.
STATUS
100% COMPLETE
FEED
RP-HPLC · LIVE
PROBE
C18 · 220nm
RT
2.14 MIN
Research Compliance
For In-Vitro Laboratory Research only. Not for human or animal consumption. This material is supplied as an analytical reference standard for laboratory research. It is not a medicine, food, cosmetic or medical device.
DOSSIER · TECHNICAL SPECIFICATION
CAS
2381089-83-2
FORMULA
C₂₂₁H₃₄₃N₄₇O₆₅
MOL. WEIGHT
4731.4 g/mol
PURITY
≥99%
FORM
Wit lyofiel poeder
SOLUBLE
Oplosbaar in bacteriostatisch water (BAC)
STABILITY
Stabiel 24 maanden @ -20°C, 30 dagen na reconstitutie @ 2-8°C
ANALYSIS
RP-HPLC · MS · NMR
VALIDATION
HPLC-CERTIFIED
SEQUENCE
Triple agonist (GLP-1 / GIP / Glucagon receptor)
IN-VITRO DOCUMENTATION
DOSSIER
RP-3
€48.74 /st
1
1